DCVC

DCVC, established in 2010 and based in Palo Alto, California, is a venture capital firm focusing on early-stage investments in deep tech companies. The firm backs entrepreneurs leveraging advanced technologies to drive transformative change across various sectors, including artificial intelligence, manufacturing, and life sciences. DCVC's portfolio comprises companies that combine cutting-edge science and technology with unique computing and algorithmic advantages, aiming to reduce capital and operational expenses. DCVC Bio, a subsidiary founded in 2018 and based in San Francisco, specializes in investing in early-stage life science companies powered by deep tech approaches, targeting sectors such as therapeutics platforms, agriculture, and industrial biotechnologies. Both DCVC and DCVC Bio are registered investment advisers.

Chris Boshuizen

Operating Partner

Jack Buendorf

Associate

Alan Cohen

General Partner

Michael Driscoll

Founding Partner

Anna Fokina

Investment Director

John Hamer

Co-Founder and Managing Partner

Justin Kern Ph.D

Partner

Andy May

Operating Partner

Patrick McCauley

Operating Partner

Matt O'Connell

Operating Partner

Joe Oleynik

Associate

Luca Parolari Ph.D

Senior Associate

Jason Pontin

General Partner and Member of Investment Team

Kristen Rocca

Principal

Monica Rogati

Equity Partner

Stephen Seymour

Associate, Investments

Eric Shiozaki

Partner

Rachel Slaybaugh

Partner

Kiersten Stead

Co-Founder and Managing Partner

Milo Werner

General Partner

522 past transactions

Grove Biopharma

Series A in 2025
Grove Biopharma is a biotechnology company dedicated to addressing significant unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. It focuses on the discovery and development of a novel class of protein-like polymers, utilizing artificial intelligence and precision polymer chemistry to create hybrid synthetic protein mimetics. In addition to its drug development efforts, Grove Biopharma provides materials science solutions to challenges associated with peptide therapeutics, enabling researchers to access innovative drugs in areas where treatment options are limited. Through its advanced platform, the company aims to contribute meaningful advancements in biotechnology and healthcare.

Mainspring

Series F in 2025
Mainspring Energy, Inc. is a technology company based in Menlo Park, California, that specializes in developing linear generator technology for low carbon, dispatchable energy solutions. Founded in 2010 by three Stanford engineers, the company focuses on creating advanced prototypes that convert fuel into electricity through a unique, low-temperature reaction of air and fuel. This innovative approach allows Mainspring to offer generators that provide affordable, reliable electricity while significantly reducing carbon emissions compared to traditional electric grids. The company's mission is to address climate change and enhance energy accessibility, contributing to the development of net-zero carbon energy systems for the future.

Solu Therapeutics

Series A in 2025
Solu Therapeutics is a precision medicine company dedicated to developing innovative therapeutics aimed at eliminating disease-driving cells. Utilizing its unique cytotoxicity-targeting chimera platform, the company focuses on creating oncology therapeutics that address not only cancer but also inflammatory and autoimmune diseases. By targeting and eliminating these harmful cells, Solu Therapeutics seeks to enhance treatment efficacy and reduce the associated risks in oncology, ultimately aiming to improve patient outcomes in various medical conditions.

Lumafield

Series C in 2025
Lumafield is a company that specializes in industrial computed tomography (CT) solutions aimed at non-destructive testing and inspection for engineers. Its flagship product, the Neptune X-ray CT scanner, offers detailed imaging capabilities that allow engineers to analyze internal structures and identify defects in various materials. Complementing this hardware is the Voyager software platform, which provides cloud-based, AI-powered analysis, facilitating automated inspections and collaborative tools for engineers. Additionally, Lumafield's Triton system is engineered for high-speed scanning, catering to high-volume manufacturing processes. The company’s solutions are utilized across multiple industries, including aerospace, automotive, electronics, and medical devices, ultimately enhancing product quality and reliability throughout the development process.

AgZen

Series A in 2025
AgZen is a company that specializes in the development of pesticide sprays designed to adhere to plants, thereby minimizing pollution associated with agricultural chemicals. The firm provides patented, field-tested food-safe additives and sprayer retrofits that enhance the adhesion of agrochemical droplets to crops. This innovative approach allows farmers to achieve effective protection while significantly reducing the volume of pesticides used, without sacrificing plant health or yield. By focusing on sustainability and efficiency, AgZen aims to support agricultural practices that are both environmentally friendly and economically viable for farmers.

Newleos Therapeutics

Series A in 2025
Newleos Therapeutics is a stealth-mode biotechnology company focused on developing safer and more effective treatments for neuropsychiatric disorders, aiming to improve mental health outcomes.

Auron Therapeutics

Series B in 2025
Auron Therapeutics, Inc. is a biotechnology company based in Wellesley, Massachusetts, founded in 2018. The company is dedicated to developing innovative therapies for cancer, aiming to shift the traditional focus from merely killing cancer cells to transforming malignant cells into normal, functioning cells through a process known as differentiation therapy. This approach seeks to reactivate the body's innate cellular programs, promoting tumor cell maturation and the restoration of normal tissue. Auron Therapeutics leverages advanced platforms that integrate large genomic datasets and utilize high-throughput flow cytometry to efficiently identify and validate potential drug targets in primary human patient samples. Through its research, the company aims to address significant unmet medical needs in oncology, ultimately striving to deliver life-saving and transformative treatments for cancer patients.

Umoja Biopharma

Series C in 2025
Umoja Biopharma is a biotechnology company specializing in innovative immunotherapy aimed at transforming cancer treatment. The company focuses on reprogramming T cells to effectively target cancer within patients' bodies, enhancing the immune response to combat both solid tumors and hematological cancers, which often show poor responses to conventional therapies. Umoja Biopharma's proprietary CAR T-cell gene therapy platform is designed to deliver scalable therapeutic regimens, allowing for tailored treatment options that can be administered to any patient, regardless of tumor type or stage. This approach aims to improve patient outcomes and quality of life by providing a safe and controllable method to attack cancer directly.

Alta Resource Technologies

Seed Round in 2025
Alta Resource Technologies specializes in innovative mining technology, utilizing advanced biochemistry to efficiently extract critical minerals, such as rare earth elements, from diverse feedstocks. Their proprietary platform employs customizable proteins for highly selective separation, reducing environmental impact and enabling clients to meet materials demand for advanced technologies like semiconductors.

Fervo Energy

Series D in 2024
Fervo Energy, established in 2017 and headquartered in San Francisco, specializes in developing and operating geothermal assets using proprietary technology. The company aims to generate clean, dispatchable power from new locations, contributing to a 100% clean energy future. Fervo's innovative approach to geoscience accelerates the development of geothermal projects, providing carbon-free energy solutions for clients seeking scalable, productive power sources.

Slip Robotics

Series B in 2024
Slip Robotics designs and develops robotic technology focused on streamlining the loading and unloading process for trucks. Their SlipBot Automated Loading Robots (ALRs) can completely load or unload a trailer in under five minutes, significantly reducing idle time for truck drivers and the risks faced by forklift operators. By automating this crucial logistics task, Slip Robotics addresses common challenges in the supply chain, such as minimizing loading times and reducing material handling damage. Their robots function independently of Wi-Fi or IT system integration, providing a frictionless solution for warehouses, distribution centers, and manufacturing facilities. This innovative approach not only enhances safety and efficiency but also enables businesses to maximize productivity with fewer personnel.

Radiant

Series C in 2024
Radiant is a clean energy startup based in Los Angeles, California, that specializes in the development of portable nuclear microreactors. Founded in 2019, the company aims to provide an alternative to fossil fuels for both military and commercial applications. Its flagship product, the Kaleidos microreactor, is designed to fit within a shipping container, allowing for transportation by air, ship, and road. This innovative microreactor serves as a zero-emissions power source, making it particularly suitable for remote locations and critical applications where traditional diesel generators are typically used.

Reality Defender

Series A in 2024
Reality Defender is a company that specializes in detecting deepfakes and AI-generated media, addressing the risks posed by manipulated content across multiple formats, including audio, video, images, and text. Its platform employs advanced synthetic media detection algorithms to identify and assess the authenticity of digital content in real time. This capability enables both enterprises and government entities to effectively combat synthetically altered media, ensuring more reliable digital communication. With a patented multimodal approach, Reality Defender offers flexible deployment options, allowing its technology to seamlessly integrate into existing infrastructures for proactive management of digital media.

Q-CTRL

Series B in 2024
Q-CTRL, established in 2017 and based in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. Its core solution focuses on reducing and controlling quantum bit errors in quantum hardware devices, a critical challenge in the field. Q-CTRL's quantum control infrastructure software caters to R&D professionals and end-users, accelerating the development of useful quantum computers. The company also develops "software-defined" quantum sensors for applications in defense, intelligence, navigation, and earth observation. Q-CTRL works with global leaders in quantum technology, including universities, national labs, and industry partners, and is an IBM Quantum Startup network member. It has received numerous awards and recognitions, including being named a World Economic Forum Global Innovator and featured in prominent international publications.

Zap Energy

Series D in 2024
Zap Energy, Inc. is a Seattle-based company that specializes in the design and manufacture of sheared-flow stabilized Z-Pinch fusion reactors for power generation. Founded in 2017, the company focuses on developing compact and scalable fusion technology that offers low-carbon, cost-effective, and flexible energy solutions. Unlike conventional fusion methods, Zap Energy's approach utilizes electric current to create magnetic fields that confine and compress plasma, enhancing the stability and efficiency of the fusion process. This innovative technology aims to provide sustainable energy while requiring less capital investment compared to traditional fusion systems.

Twelve

Series C in 2024
Twelve, formerly known as Opus 12, is a Berkeley, California-based company that specializes in recycling carbon dioxide emissions into valuable chemicals and fuels. Founded in 2015, the company has developed innovative technology that can be integrated with any source of CO₂ emissions. By utilizing only water and electricity as inputs, Twelve transforms captured carbon dioxide into essential products such as methane, ethylene, and ethanol. The firm aims to provide a cost-competitive alternative to petroleum-derived chemicals and fuels, thereby addressing carbon emissions while simultaneously creating economically viable solutions.

Tidal Metals

Seed Round in 2024
Tidal Metals developed a breakthrough suite of innovations for producing critical minerals and metals from seawater and brines – with no waste, no carbon emissions, and no harm to the environment.

SyntaxBio

Seed Round in 2024
SyntaxBio develops CRISPR/Cas9-based, genetic programming platform that converts cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform can program cells without the need for consistent external intervention.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

unspun

Series B in 2024
Unspun, Inc. is a digital apparel company based in San Francisco, California, founded in 2015. It specializes in creating custom jeans tailored to individual consumers using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental challenges by minimizing pattern-cutting waste and unsold inventory, thus contributing to a reduction in global carbon emissions. Unspun's innovative approach enables on-demand production of jeans in under ten minutes, utilizing localized manufacturing processes designed to be zero-waste. Its technology has gained recognition, including being named one of TIME's Best Inventions of 2019, and supports a B2B platform that facilitates digital customization for major apparel brands.

ZwitterCo

Series B in 2024
ZwitterCo specializes in advanced membrane solutions for the treatment of highly impaired wastewater, enabling the reuse and recycling of water resources in industrial applications. The company's innovative reverse osmosis and nanofiltration technologies address the challenges of treating historically unfilterable streams by preventing fouling caused by organic molecules. ZwitterCo's membranes are chlorine-tolerant, back-washable, and resistant to irreversible fouling, which enhances their longevity and performance. By transforming wastewater from a liability into a valuable resource, ZwitterCo helps clients manage their water treatment needs more economically and sustainably, reducing chemical demands and improving operational efficiency.

Samsara Eco

Series A in 2024
Samsara Eco is an innovative environmental technology company focused on addressing plastic pollution through its advanced enzymatic recycling processes. The company utilizes groundbreaking technology that employs plastic-eating super enzymes to decompose plastics into their fundamental components. This allows the recycled materials to be reused repeatedly as high-quality inputs for new plastic products or transformed into more valuable commodities. By breaking down plastics regardless of their color or shape, Samsara Eco aims to create a sustainable solution for the plastic waste crisis, enabling manufacturers to produce new plastic items from recycled materials with the same quality as virgin inputs.

Valar Labs

Series A in 2024
Valar Labs, founded in 2021 by Anirudh Joshi, Viswesh Krishna, Pranav Rajpurkar, and Damir Vrabac, is a healthcare technology company focused on enhancing cancer treatment through the use of artificial intelligence. The company has developed a software platform that analyzes imaging data, which is routinely collected in clinical settings, to provide oncologists with interpretable and actionable insights. By leveraging patient-specific characteristics, Valar Labs aims to support oncologists in making informed treatment decisions, ultimately improving patient outcomes in cancer care.

Latus Bio

Series A in 2024
Latus Bio is a biotechnology company dedicated to developing innovative gene therapies for neurological diseases. It specializes in novel discovery approaches using non-human primate models, enabling precise delivery of therapeutic genes to targeted cells within the central nervous system. Latus Bio aims to enhance clinical safety and manufacturing efficiency by administering low doses of its proprietary adeno-associated virus (AAV) capsids.

Relation Therapeutics

Seed Round in 2024
Relation Therapeutics is a biotechnology company focused on advancing drug discovery and development. It utilizes human genetics and clinical omics data, alongside patient-derived tissue samples, to identify and validate therapeutic programs. The company employs machine learning to explore the relationships between genes, proteins, and drugs, generating insights that have real translational validity. By combining single-cell multi-omics from patient tissues with functional assays, Relation Therapeutics aims to deepen the understanding of biological processes in human health and disease. This approach enables healthcare providers to discover and develop novel treatments, particularly in areas with unmet medical needs.

Fervo Energy

Series D in 2024
Fervo Energy, established in 2017 and headquartered in San Francisco, specializes in developing and operating geothermal assets using proprietary technology. The company aims to generate clean, dispatchable power from new locations, contributing to a 100% clean energy future. Fervo's innovative approach to geoscience accelerates the development of geothermal projects, providing carbon-free energy solutions for clients seeking scalable, productive power sources.

Frontier Medicines

Series C in 2024
Frontier Medicines Corporation, established in 2018 and headquartered in South San Francisco, California, is a pre-clinical stage biopharmaceutical company specializing in cancer research. The company employs chemoproteomics to discover and develop novel medicines targeting cancer-causing proteins. Frontier Medicines' innovative platform integrates advanced computational methods and machine learning algorithms to identify and pharmacologically target new binding pockets on proteins, thereby enabling small-molecule drug discovery and development for previously inaccessible targets.

Insight M

Series D in 2024
Insight M specializes in developing innovative aerial monitoring technology focused on methane detection for the energy sector. Utilizing a combination of physical science expertise and advanced data analytics, the company surveys extensive areas and generates digital maps using optical and infrared wavelengths. This technology allows Insight M to meticulously scan pipelines and vast territories to pinpoint significant sources of gas loss. By facilitating comprehensive data collection about both the natural environment and human infrastructure, Insight M aims to enhance operational efficiency and safety within the oil and gas industry. Notably, the company carried out the first-ever basin-wide aerial survey for methane detection in the Permian Basin in 2019, underscoring its commitment to improving methane management practices.

Unlearn.AI

Series C in 2024
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Elo Life Systems

Series A in 2024
Elo Life Systems is a biotechnology company dedicated to enhancing human health and wellness through innovative food solutions. The company aims to bridge the gap between food, agriculture, and health by employing precision gene editing and breeding technologies, genomics, and data analytics. Through partnerships with stakeholders across the food systems value chain, Elo focuses on improving agricultural productivity, meeting nutritional demands, and addressing food security challenges. By replacing sugar and artificial sweeteners with healthier alternatives, Elo Life Systems empowers individuals to enjoy their favorite foods while promoting healthier lifestyles.

Equilibrium Energy

Funding Round in 2023
Equilibrium Energy is a company focused on transforming the energy sector by developing an innovative energy management platform that optimizes energy consumption and reduces costs. Operating at the intersection of grid variability and market volatility, the company provides advanced solutions that enable users to enhance sustainability and achieve significant efficiency in their energy usage. By addressing the challenges of economic optimization, commercial structuring, trading, and risk management, Equilibrium Energy aims to reshape the energy industry and contribute to a greener future. Their commitment to leveraging technology and data-driven insights positions them as a next-generation clean power company dedicated to improving energy management across the entire power value chain.

Totus Medicines

Series B in 2023
Totus Medicines is a biotechnology company focused on developing innovative therapies for diseases that have been historically difficult to treat. Utilizing advanced chemical biology techniques, the company employs a proprietary platform that enables high-throughput screening of billions of drug candidates against numerous biological targets. This approach allows Totus Medicines to identify effective molecules for traditionally challenging conditions, including cancer, Alzheimer's disease, infectious diseases, and age-related disorders. By harnessing the potential of covalent bonding and cutting-edge drug discovery methods, Totus Medicines aims to translate genetic insights into viable therapeutic options, addressing unmet medical needs across the human genome.

Fourth Power

Series A in 2023
Fourth Power is an energy storage startup that specializes in thermal battery technology. The company focuses on utility-scale thermal storage to convert excess renewable energy from sources like wind and solar into a reliable, on-demand energy supply. Its innovative storage solutions are designed to optimize the use of wasted renewable energy production, effectively addressing grid demands while reducing reliance on fossil fuels. Fourth Power offers a modular storage system that can adapt and expand alongside the grid, providing both short-duration and long-duration energy storage capabilities. This flexibility enables clients to enhance their energy management and allows grid operators to control the timing and usage of stored energy, facilitating a smoother transition to fully decarbonized infrastructure.

Reality Defender

Series A in 2023
Reality Defender is a company that specializes in detecting deepfakes and AI-generated media, addressing the risks posed by manipulated content across multiple formats, including audio, video, images, and text. Its platform employs advanced synthetic media detection algorithms to identify and assess the authenticity of digital content in real time. This capability enables both enterprises and government entities to effectively combat synthetically altered media, ensuring more reliable digital communication. With a patented multimodal approach, Reality Defender offers flexible deployment options, allowing its technology to seamlessly integrate into existing infrastructures for proactive management of digital media.

Relay

Seed Round in 2023
Relay specializes in business automation technology aimed at enhancing team productivity and efficiency. By providing a platform that establishes and streamlines core workflows, Relay enables organizations to automate routine tasks and improve coordination among team members. This approach allows leaders to manage their teams more effectively, ensuring that workflows are executed on time and reducing the burden of tedious coordination. Through its solutions, Relay supports enterprises in achieving better alignment and operational effectiveness.

Mach Industries

Series A in 2023
Mach Industries is a defense technology company focused on developing innovative solutions that utilize hydrogen as a fuel source for defense systems. The company aims to transform military capabilities by creating weapon systems for the United States and its allies that leverage the chemical reaction of oxygen and hydrogen to produce explosive energy. Through a vertically integrated energy chain, Mach Industries enables the development of unmanned aerial vehicles and aerial protection devices powered by hydrogen combustion, utilizing techniques for producing and combusting hydrogen sourced from the field. This approach not only enhances operational efficiency but also aligns with modern sustainability goals in defense technology.

Noetik

Seed Round in 2023
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

CH4 Global

Series B in 2023
CH4 Global Inc. is a holding company focused on producing seaweed bio-products aimed at reducing methane emissions from livestock, particularly ruminants such as cows, goats, sheep, and deer. Founded in 2019 and based in San Francisco, California, the company specializes in Asparagopsis armata, a seaweed supplement proven to decrease enteric methane emissions by up to 90%. CH4 Global operates through subsidiaries in the United States, Australia, New Zealand, and the Pacific, leveraging established scientific and technological methods to develop innovative livestock feed additives. The company aims to mitigate greenhouse gas emissions on a large scale, supporting both environmental sustainability and economic benefits for farmers and food producers through potential carbon credits and premium pricing for their products.

Verdigris

Venture Round in 2023
Verdigris Technologies, Inc. is a technology company based in Moffett Field, California, that specializes in software solutions for electricity monitoring in commercial facilities. Established in 2010, the company has developed an artificial intelligence-driven IoT platform designed to enhance energy efficiency and optimize operations in large buildings. Its flagship product, Verdigris Energy Tracker, automates building management by identifying operational inefficiencies, predicting demand peaks, and detecting equipment failures. The platform includes Building.AI, a cloud analytics software that provides enterprise facilities managers with real-time insights into energy consumption at the device level. By utilizing advanced machine learning and embedded wireless sensors, Verdigris enables smarter facility operations, energy demand management, and improved property management, ultimately helping organizations reduce energy costs and enhance operational efficiency.

Radionetics Oncology

Series A in 2023
Radionetics Oncology is a biopharmaceutical company dedicated to the discovery and development of innovative radiotherapeutics aimed at treating various oncology indications. The company specializes in creating non-peptide and small molecule therapies that facilitate the targeted delivery of therapeutic radioisotopes to solid tumors. By focusing on these advanced treatment options, Radionetics Oncology seeks to enhance the effectiveness of cancer therapies and improve patient outcomes in oncology care.

Solu Therapeutics

Seed Round in 2023
Solu Therapeutics is a precision medicine company dedicated to developing innovative therapeutics aimed at eliminating disease-driving cells. Utilizing its unique cytotoxicity-targeting chimera platform, the company focuses on creating oncology therapeutics that address not only cancer but also inflammatory and autoimmune diseases. By targeting and eliminating these harmful cells, Solu Therapeutics seeks to enhance treatment efficacy and reduce the associated risks in oncology, ultimately aiming to improve patient outcomes in various medical conditions.

Plotlogic

Series B in 2023
Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

Kanvas Biosciences

Seed Round in 2023
Our full-stack tech­nol­o­gy plat­form brings micro­bio­me drug dis­cov­ery into focus. Our spa­tial map­ping dis­cov­ery engine pro­vides stun­ning pic­tures of the inter­ac­tions and con­nec­tions between host and the micro­bio­me; an area of this vital sys­tem that we’ve nev­er been able to com­plete­ly under­stand before. Spa­tial biol­o­gy of the host-micro­bio­me inter­face pro­vides new oppor­tu­ni­ties for effec­tive ther­a­peu­tic inter­ven­tions, ulti­mate­ly enabling us to bet­ter treat patients.

Nium

Seed Round in 2023
Nium is a climate technology company focused on decarbonizing industry through innovative nanotechnology. The company has developed a nanocatalyst reactor that facilitates the on-site synthesis of ammonia, utilizing renewable energy sources. This system, known as Green Ammonia on Demand, allows for the decentralized production of ammonia, which can be stored and transported efficiently. By integrating its reactor with hydrogen-producing facilities, Nium aims to significantly reduce carbon dioxide emissions, thereby helping industries lower their carbon footprints and contribute to a more sustainable economy.

Demox Labs

Pre Seed Round in 2023
Demox Labs is a technology company that specializes in developing a decentralized oracle protocol to connect smart contracts with off-chain data sources. Founded in 2021 and based in Walnut Creek, California, the company offers a solution that bridges the data gap between web2 and web3, thereby facilitating the use of online data in smart contract development. Demox Labs also focuses on enhancing privacy for users by creating privacy-preserving wallets tailored for the web3 environment. By turning any website into an oracle, the platform enables the efficient relay of data across various blockchain networks, ultimately aiming to improve the global payment structure and provide clients with secure cryptocurrency wallet solutions.

Auradine

Series A in 2023
Auradine is a provider of web infrastructure solutions focused on blockchain, security, and privacy. The company develops a comprehensive platform that encompasses hardware, software, and cloud services, aimed at creating scalable, sustainable, and secure infrastructure. With a proven track record in security, software-as-a-service, semiconductors, and systems, Auradine leverages cutting-edge technologies to deliver innovative infrastructure solutions tailored to meet the needs of its clients.

Ascend Gene & Cell Therapies

Series A in 2023
Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.

Charlie

Seed Round in 2023
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.

Ninjatech.ai

Seed Round in 2023
Ninjatech.ai is a developer of a conversational artificial intelligence platform aimed at enhancing productivity for professionals. The company provides access to advanced generative AI and language models, allowing users to efficiently complete tasks through its innovative AI agents. By focusing on democratizing access to cutting-edge AI technologies, Ninjatech.ai seeks to empower individuals and organizations globally, ultimately fostering safer, happier, and more productive work environments. The platform represents a significant advancement in conversational AI, catering specifically to the needs of working professionals.

Halter

Series C in 2023
Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in developing GPS-enabled, solar-powered tracking devices for livestock. The company manufactures innovative collars designed for cows, allowing farmers to monitor and guide their animals across pastures. Halter's technology enables virtual fencing, helping farmers optimize productivity while promoting sustainable farming practices. By enhancing the management of livestock, Halter aims to improve agricultural efficiency and animal welfare, contributing to the overall sustainability of pasture-based farming.

Amogy

Series B in 2023
Amogy is a pioneering company focused on developing carbon-free energy solutions for hard-to-abate sectors such as maritime transport, power generation, and heavy industries. The company's core technology involves patented ammonia cracking, which efficiently splits liquid ammonia to produce electrical power in conjunction with hydrogen fuel cells, enabling zero-emission operations at competitive costs.

Shennon Biotechnologies

Seed Round in 2023
Shennon Biotechnologies focuses on the analysis and manipulation of immune cells at the single-cell level to enhance the development of treatments for human diseases, particularly cancer. Utilizing a proprietary single-cell platform, the company profiles millions of immune cells simultaneously, allowing for the identification of rare and difficult-to-find targets that are crucial for advancing immunotherapy. By addressing a significant bottleneck in the field of immunotherapy, Shennon Biotechnologies aims to enable the creation of more targeted and effective immunotherapies, thereby contributing to improved therapeutic outcomes in the medical industry.

Mythic

Venture Round in 2023
Mythic Inc. is a technology company specializing in the design and development of silicon chips and artificial intelligence processing units (IPUs). Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic focuses on integrating AI capabilities into a wide range of devices, including fitness bands, hearing aids, self-driving cars, and robotic drones. The company leverages its unique analog compute-in-memory technology to create products like the M1076 Analog Matrix Processor and MP10304 Quad-AMP PCIe Card, delivering desktop-grade graphics processing in compact formats. With a diverse team of experts in neural networks, device physics, software design, and processor architecture, Mythic is committed to advancing AI solutions that perform reliably in real-world environments, enhancing the functionality of consumer electronics and other applications while maintaining performance and power efficiency.

Fulfil Solutions

Series B in 2023
Fulfil Solutions is a developer of advanced robotic automation technology aimed at transforming the online grocery sector. The company specializes in creating a fully automated fulfillment system designed to enhance profitability while addressing food supply chain challenges. By integrating mechanical design, software, robotics, computer vision, and deep learning, Fulfil Solutions offers solutions that streamline picking, packing, and inventory control across various product categories and temperature zones. Their innovative technology seeks to reduce waste, minimize environmental impact, and lower emissions, enabling companies to automate their supply chain processes effectively within a compact operational footprint. Through these advancements, Fulfil Solutions supports sustainable and customer-centric online grocery operations at scale.

Aquafortus

Series A in 2023
Aquafortus specializes in non-thermal crystallization technology aimed at recovering clean water and crystallizing salts from high-salinity brines. The company addresses the treatment needs of various industries, including cooling towers, mining, oil and gas, inland desalination, and flue gas desulfurization from power generation. By significantly reducing energy consumption, Aquafortus enhances the economic viability of liquid transportation, wastewater management, and zero liquid discharge processes. This innovative approach enables clients to lower their operating expenses while effectively managing high-salinity waste.

Fortem Technologies

Venture Round in 2023
Fortem Technologies, Inc. is a privately held company based in Provo, Utah, specializing in AI-enabled airspace security and safety solutions. Founded in 2016, Fortem develops and manufactures advanced intrusion detection and detect-and-avoid systems that alert, identify, and classify drones and other unmanned aerial vehicles (UAVs). Its product offerings include various radar systems, such as the DAA-R10 and DAA-R20, designed for mission-critical operations and compliance with FAA standards. Additionally, the company provides the ThreatAware AI analysis engine, which processes data from multiple sensors in real-time, and the F700 Patriot, a multi-rotor drone platform. Fortem's DroneHunter, a military-tested unmanned aircraft, is designed for perimeter intrusion detection and protection. Through its innovative technologies, Fortem enables organizations to enhance operational safety and transition unmanned aircraft operations beyond visual line of sight (BVLOS).

Elo Life Systems

Series A in 2023
Elo Life Systems is a biotechnology company dedicated to enhancing human health and wellness through innovative food solutions. The company aims to bridge the gap between food, agriculture, and health by employing precision gene editing and breeding technologies, genomics, and data analytics. Through partnerships with stakeholders across the food systems value chain, Elo focuses on improving agricultural productivity, meeting nutritional demands, and addressing food security challenges. By replacing sugar and artificial sweeteners with healthier alternatives, Elo Life Systems empowers individuals to enjoy their favorite foods while promoting healthier lifestyles.

Evonetix

Series B in 2023
Evonetix Ltd is a biotechnology company based in Little Chesterford, United Kingdom, founded in 2015. The company specializes in the development of a novel technology that allows for the parallel synthesis of DNA on silicon arrays, thereby advancing the field of synthetic biology. Evonetix aims to enhance DNA synthesis accuracy and scalability, making it accessible to researchers and transforming how DNA is produced and utilized for gene synthesis. With a highly experienced engineering team that combines expertise from various scientific and engineering disciplines, Evonetix is positioned to significantly impact the capabilities of synthetic biology by enabling applications that were previously unfeasible.

Recycleye

Series A in 2023
Recycleye Limited, founded in London in 2019 by Victor Dewulf, develops AI-powered machine learning tools for waste management. These tools facilitate waste characterization, tracking, and automated sorting, empowering users to transition towards a more circular economy efficiently.

Nest Genomics (YC W22)

Seed Round in 2023
Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.

Burnbot

Seed Round in 2022
BurnBot is a provider of innovative fuel treatment services aimed at preventing destructive wildfires. The company specializes in systematic wildfire mitigation and vegetation management by utilizing advanced forestry and fire technology. BurnBot offers solutions that include safe smoke containment and a modular system for controlled burns, which can be strategically deployed near homes and valuable assets. By employing high-temperature ignition methods, BurnBot helps create effective firebreaks and defensible spaces, thereby protecting communities, infrastructure, and natural resources from the threat of wildfires.

Reach

Series B in 2022
Reach is a technology company specializing in long-range wireless power networks that offer scalable and resilient energy infrastructure. Its innovative wireless power solution transforms power delivery in a manner similar to how Wi-Fi revolutionized data connectivity. The Reach system incorporates advanced, patented technologies, including high-efficiency power beaming circuits and network optimization algorithms, to create a safe and user-friendly power platform. This technology is particularly well-suited for various industries, including manufacturing, government, energy, logistics, and retail, enabling devices to operate without reliance on traditional power cables through the use of radio frequency transmission and proprietary antenna structures.

Verdant Robotics

Series A in 2022
Verdant Robotics, Inc., founded in 2018 and based in Hayward, California, specializes in artificial intelligence-driven robotic solutions for agriculture. The company develops advanced technologies that enable farmers to digitally map their fields and monitor each plant's health over time. Verdant's flagship product, the Model B Smart Sprayer, significantly reduces labor costs by over 50% and input costs by up to 96% while providing precise weeding and thinning for various crop types. Utilizing proprietary Bullseye targeting technology and a Pinpoint Spray System, Verdant promotes micro-fertilization and nutrient delivery, enhancing crop yields and efficiency. By leveraging robotics, computer vision, and machine learning, Verdant Robotics empowers growers of all sizes to optimize production and improve profitability in the agricultural sector.

Smartex.ai

Series A in 2022
Smartex focuses on addressing significant challenges in the textile industry by leveraging advanced AI technology, specifically machine learning and computer vision. The company has developed a hardware-enabled software solution that detects textile defects and irregularities in real time. By implementing this innovative system, Smartex can halt production when defects are identified, thereby minimizing defective output and reducing textile waste. This proactive approach not only enhances production efficiency but also contributes to sustainability by lowering carbon dioxide emissions, energy consumption, and water usage. Moreover, Smartex provides factories with a user interface to monitor production statistics, further improving operational insights and decision-making capabilities.

Samsara Eco

Series A in 2022
Samsara Eco is an innovative environmental technology company focused on addressing plastic pollution through its advanced enzymatic recycling processes. The company utilizes groundbreaking technology that employs plastic-eating super enzymes to decompose plastics into their fundamental components. This allows the recycled materials to be reused repeatedly as high-quality inputs for new plastic products or transformed into more valuable commodities. By breaking down plastics regardless of their color or shape, Samsara Eco aims to create a sustainable solution for the plastic waste crisis, enabling manufacturers to produce new plastic items from recycled materials with the same quality as virgin inputs.

ZwitterCo

Series A in 2022
ZwitterCo specializes in advanced membrane solutions for the treatment of highly impaired wastewater, enabling the reuse and recycling of water resources in industrial applications. The company's innovative reverse osmosis and nanofiltration technologies address the challenges of treating historically unfilterable streams by preventing fouling caused by organic molecules. ZwitterCo's membranes are chlorine-tolerant, back-washable, and resistant to irreversible fouling, which enhances their longevity and performance. By transforming wastewater from a liability into a valuable resource, ZwitterCo helps clients manage their water treatment needs more economically and sustainably, reducing chemical demands and improving operational efficiency.

Novome Biotechnologies

Series B in 2022
Novome Biotechnologies, Inc. is a biotechnology company specializing in the engineering of gut bacteria to create innovative therapies for chronic diseases. Established in 2015 and located in South San Francisco, California, Novome has developed a pioneering platform for the controlled colonization of the gut with genetically engineered microbial medicines (GEMMs). This platform allows for the precise delivery of therapeutic activities aimed at treating conditions such as hyperoxaluria, with a focus on creating a bacterial strain that can degrade oxalate to help prevent kidney stone formation. The company is also expanding its synthetic biology capabilities to explore additional therapeutic indications, aiming to improve long-term health outcomes for patients through its living therapeutics.

Fervo Energy

Series C in 2022
Fervo Energy, established in 2017 and headquartered in San Francisco, specializes in developing and operating geothermal assets using proprietary technology. The company aims to generate clean, dispatchable power from new locations, contributing to a 100% clean energy future. Fervo's innovative approach to geoscience accelerates the development of geothermal projects, providing carbon-free energy solutions for clients seeking scalable, productive power sources.

Auron Therapeutics

Series A in 2022
Auron Therapeutics, Inc. is a biotechnology company based in Wellesley, Massachusetts, founded in 2018. The company is dedicated to developing innovative therapies for cancer, aiming to shift the traditional focus from merely killing cancer cells to transforming malignant cells into normal, functioning cells through a process known as differentiation therapy. This approach seeks to reactivate the body's innate cellular programs, promoting tumor cell maturation and the restoration of normal tissue. Auron Therapeutics leverages advanced platforms that integrate large genomic datasets and utilize high-throughput flow cytometry to efficiently identify and validate potential drug targets in primary human patient samples. Through its research, the company aims to address significant unmet medical needs in oncology, ultimately striving to deliver life-saving and transformative treatments for cancer patients.

Twelve

Series B in 2022
Twelve is a company that focuses on providing innovative cashless payment solutions tailored for various industries, including sports, events, catering, and museums. The company has developed a user-friendly online cash register and payment system designed primarily for sports clubs, which facilitates point-of-sale transactions and supports digital pricing along with debit and credit payments. Twelve aims to enhance the payment experience for clients by offering software modules, ordering solutions, and communication tools, thereby helping entrepreneurs and organizers achieve greater success in their initiatives.

Sabanto

Series A in 2022
Sabanto is a company that offers a Farming-as-a-Service solution aimed at enhancing autonomy in agricultural machinery. It specializes in low-cost retrofitting of existing agricultural equipment, irrespective of brand or model, and develops software that supports the functionality of autonomous technology. This approach not only improves the utility of farming equipment but also aims to increase the return on investment for producers. Sabanto's technology facilitates comprehensive agricultural services through a supervised autonomous equipment platform, allowing farmers to monitor and operate their operations efficiently from a centralized location. By focusing on simple and cost-effective innovations, Sabanto is dedicated to advancing the future of agriculture.

Twelve

Series B in 2022
Twelve, formerly known as Opus 12, is a Berkeley, California-based company that specializes in recycling carbon dioxide emissions into valuable chemicals and fuels. Founded in 2015, the company has developed innovative technology that can be integrated with any source of CO₂ emissions. By utilizing only water and electricity as inputs, Twelve transforms captured carbon dioxide into essential products such as methane, ethylene, and ethanol. The firm aims to provide a cost-competitive alternative to petroleum-derived chemicals and fuels, thereby addressing carbon emissions while simultaneously creating economically viable solutions.

Relation Therapeutics

Seed Round in 2022
Relation Therapeutics is a biotechnology company focused on advancing drug discovery and development. It utilizes human genetics and clinical omics data, alongside patient-derived tissue samples, to identify and validate therapeutic programs. The company employs machine learning to explore the relationships between genes, proteins, and drugs, generating insights that have real translational validity. By combining single-cell multi-omics from patient tissues with functional assays, Relation Therapeutics aims to deepen the understanding of biological processes in human health and disease. This approach enables healthcare providers to discover and develop novel treatments, particularly in areas with unmet medical needs.

Zap Energy

Series C in 2022
Zap Energy, Inc. is a Seattle-based company that specializes in the design and manufacture of sheared-flow stabilized Z-Pinch fusion reactors for power generation. Founded in 2017, the company focuses on developing compact and scalable fusion technology that offers low-carbon, cost-effective, and flexible energy solutions. Unlike conventional fusion methods, Zap Energy's approach utilizes electric current to create magnetic fields that confine and compress plasma, enhancing the stability and efficiency of the fusion process. This innovative technology aims to provide sustainable energy while requiring less capital investment compared to traditional fusion systems.

Sickbay

Venture Round in 2022
Sickbay is a healthcare services company that specializes in patient monitoring and analytics. Founded in 1999, Sickbay offers a software platform designed to assist healthcare professionals by providing comprehensive access to patient data, including medical histories and real-time monitoring from various devices. Its solutions focus on automating documentation and improving alarm management, which helps reduce unnecessary alarm noise and ensures that care providers receive pertinent alerts. Additionally, Sickbay engages in the wholesale marketing of FDA-authorized nutritional supplements, aimed at supporting hospital professionals and medical staff in delivering informed, data-driven patient care.

Zeno Power

Series A in 2022
Zeno Power is a company that creates advanced power systems that use radioisotopes. The company intends to increase the production of small-scale nuclear batteries capable of powering spacecraft and undersea technologies for years. Zeno, founded in 2018 by three Vanderbilt University students, intends to be the first to enter the commercial market with a novel new combination of affordability and lightweight.

Capella Space

Series C in 2022
Capella Space Corp. is a San Francisco-based company that manufactures and operates a constellation of commercial radar satellites, providing high-resolution synthetic aperture radar (SAR) imagery with a resolution of 50 centimeters. Founded in 2016, the company delivers on-demand Earth observation services that enable continuous global coverage, regardless of weather conditions or time of day. Capella's satellite technology is utilized across various industries for applications such as maritime domain awareness, urban planning, disaster response, and monitoring economic activities. By offering timely and flexible information, Capella Space aims to enhance decision-making in commerce, conservation, and security, ultimately contributing to improved outcomes in infrastructure monitoring, agriculture, and disaster recovery efforts.

Agility Robotics

Series B in 2022
Agility Robotics Inc. is a robotics development company based in Albany, Oregon, founded in 2015. It specializes in designing and developing advanced robotic machines, particularly focusing on bipedal robots like Cassie, which are capable of walking and running. The company leverages a rich history of academic research, including the development of the ATRIAS robot, to create legged locomotion systems that provide human-like mobility. Agility Robotics aims to address real-world needs by offering efficient, agile, and robust mobility platforms that can operate alongside humans with minimal additional programming. Its products are designed for various applications in academic, corporate, and military settings, enabling clients to automate tasks in diverse environments without the need to modify existing infrastructures.

Unlearn.AI

Series B in 2022
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Aclarity

Seed Round in 2022
Aclarity, LLC is a United States-based manufacturer specializing in innovative water purification devices for residential use. Founded in 2017, the company develops advanced electrochemical water treatment systems that effectively eliminate contaminants such as pathogens, metals, volatile organic compounds (VOCs), per- and polyfluoroalkyl substances (PFAS), and ammonia from water. Aclarity's patented technology aims to provide cost-effective, low-maintenance solutions for comprehensive water treatment, catering to the growing need for clean water and addressing pollution challenges in both water and wastewater systems. As a venture capital-backed cleantech startup, Aclarity is focused on revolutionizing the water treatment industry with its cutting-edge approach.

zkLend

Seed Round in 2022
zkLend is a Layer 2 money-market protocol developed on StarkNet that leverages zk-rollup technology to enhance transaction speed and reduce costs while maintaining the security of the Ethereum network. The platform is designed to facilitate decentralized financial transactions, allowing users to engage in money-market activities without compromising their privacy. By combining the scalability advantages of zk-rollups with Ethereum's robust security features, zkLend aims to provide an efficient and secure environment for users in the decentralized finance space.

Brimstone

Series A in 2022
Brimstone is a company based in Oakland, California, that specializes in developing a carbon-negative process for producing ordinary Portland cement and supplementary cementitious material. Established in 2019 by Cody Finke and Hugo Leandri, Brimstone's technology employs carbon-free calcium silicate rock as a substitute for limestone, resulting in a product that matches the performance of conventional materials while being cost-competitive at scale. This innovative approach aims to provide the construction industry with a cleaner and more sustainable alternative to traditional cement production methods.

Plotlogic

Series A in 2022
Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

Creyon Bio

Series A in 2022
Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.

Rill Data

Seed Round in 2022
Rill Data offers a streamlined solution for data analytics by integrating a SQL-based data modeler, a real-time database, and a metrics dashboard into a single managed cloud service platform. The company targets businesses that rely on event streaming and require real-time insights, such as e-commerce sites and digital marketing platforms. Rill Data simplifies the process of creating and consuming metrics, allowing users to analyze and optimize their data efficiently. This enables organizations to share insights with colleagues and external partners, facilitating informed decision-making and enhancing collaboration. By providing an accessible alternative to complex business intelligence stacks, Rill Data ensures that users can easily transition from data to actionable metrics.

Remedy Robotics

Seed Round in 2022
Remedy Robotics is a developer of innovative remote-controlled endovascular robots aimed at improving access to medical interventions worldwide. The company specializes in automating the procedure of mechanical thrombectomy, a crucial treatment for stroke patients. By enhancing the efficiency and effectiveness of endovascular interventions, Remedy Robotics seeks to ensure timely care, ultimately reducing the risk of severe disabilities resulting from strokes. Through its advancements in robotic technology, the company is committed to transforming the landscape of emergency medical care.

Amogy

Series A in 2021
Amogy is a pioneering company focused on developing carbon-free energy solutions for hard-to-abate sectors such as maritime transport, power generation, and heavy industries. The company's core technology involves patented ammonia cracking, which efficiently splits liquid ammonia to produce electrical power in conjunction with hydrogen fuel cells, enabling zero-emission operations at competitive costs.

Totus Medicines

Series A in 2021
Totus Medicines is a biotechnology company focused on developing innovative therapies for diseases that have been historically difficult to treat. Utilizing advanced chemical biology techniques, the company employs a proprietary platform that enables high-throughput screening of billions of drug candidates against numerous biological targets. This approach allows Totus Medicines to identify effective molecules for traditionally challenging conditions, including cancer, Alzheimer's disease, infectious diseases, and age-related disorders. By harnessing the potential of covalent bonding and cutting-edge drug discovery methods, Totus Medicines aims to translate genetic insights into viable therapeutic options, addressing unmet medical needs across the human genome.

Petra

Series A in 2021
Petra is a robotics company specializing in underground utility solutions. The firm has developed advanced tunneling robots designed to efficiently and safely bore utility conduits through various geological conditions, including high-grade hard rock. By enabling the undergrounding of critical utilities, Petra provides a practical and cost-effective means to construct small-diameter infrastructure, particularly in disaster-prone areas. Their technology addresses the challenges of traditional tunneling methods, making it feasible to install essential utilities in previously inaccessible locations.

Q-CTRL

Series B in 2021
Q-CTRL, established in 2017 and based in Pyrmont, Australia, specializes in developing software tools and firmware for the quantum computing sector. Its core solution focuses on reducing and controlling quantum bit errors in quantum hardware devices, a critical challenge in the field. Q-CTRL's quantum control infrastructure software caters to R&D professionals and end-users, accelerating the development of useful quantum computers. The company also develops "software-defined" quantum sensors for applications in defense, intelligence, navigation, and earth observation. Q-CTRL works with global leaders in quantum technology, including universities, national labs, and industry partners, and is an IBM Quantum Startup network member. It has received numerous awards and recognitions, including being named a World Economic Forum Global Innovator and featured in prominent international publications.

nTopology

Series D in 2021
nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Kettle

Series A in 2021
Kettle Inc. is an innovative company focused on providing an online risk analysis platform specifically for the insurance industry. Founded in 2020 and based in Kensington, California, Kettle utilizes advanced machine learning techniques, including deep learning algorithms and Swarm Neural Networks, to analyze over seven billion lines of data from satellite, weather, and ground truth sources. This technology enables the company to assess and mitigate risks associated with climate change, ultimately allowing insurers to underwrite catastrophic risks more effectively. Kettle's platform is designed to balance risk by offering reinsurance solutions to insurance providers, helping them manage their portfolios in an increasingly unpredictable climate.

Gradle Enterprise

Series C in 2021
Gradle Inc. is a company that specializes in enhancing developer productivity through its innovative software solutions, notably Develocity, which was formerly known as Gradle Enterprise. The firm is also the creator of the widely used open-source Gradle Build Tool, which sees over 30 million downloads each month. Gradle is at the forefront of Developer Productivity Engineering (DPE), a practice adopted by prominent organizations such as Airbnb, LinkedIn, Microsoft, Nasdaq, and Netflix. These elite teams utilize Develocity’s advanced technologies and analytics to accelerate build and test performance, thereby improving the reliability of their developer toolchains and streamlining the troubleshooting of failures. By automating and unifying the build processes, Gradle enables enterprises to effectively build, deliver, and maintain complex applications, thereby enhancing their capability to ship software efficiently and cost-effectively.

StarkWare Industries

Series C in 2021
StarkWare Industries Ltd is a technology company based in Netanya, Israel, established in 2017. The company specializes in developing software and hardware solutions focused on the generation and verification of computational integrity proofs. Its primary offering, known as STARK, is a zero-knowledge proof protocol that enhances privacy in blockchain applications, increases transaction throughput, and enables off-chain computation. StarkWare Industries aims to create a comprehensive proof stack to facilitate secure and efficient computational processes across various applications.

Jupiter Intelligence

Series C in 2021
Jupiter Intelligence, Inc. is a technology company that specializes in climate risk analytics, providing tools and platforms to assess the impacts of weather and climate change. Founded in 2017 and based in San Mateo, California, Jupiter offers the ClimateScore Intelligence Platform, which utilizes cloud computing to integrate various predictive models that process data from numerous ground-based and satellite sensors. The company's offerings include Jupiter FloodScore, which assists users in preparing for potential flooding, and Jupiter HeatScore, which predicts extreme temperatures to help organizations mitigate heat- and cold-related risks. By transforming complex climate science into actionable data, Jupiter enables businesses to proactively manage and disclose climate risks, helping them navigate the increasing frequency and severity of extreme weather events.

TrustPoint

Seed Round in 2021
TrustPoint is developing a next-generation GPS signal processing technology to provide the performance and reliability required for safety-critical automation, vital infrastructure, and seamless augmented reality.

MosaicML

Venture Round in 2021
MosaicML is a company focused on creating an efficient infrastructure for training large language models and improving the overall efficiency of neural networks. It develops software and artificial intelligence training algorithms that enhance the training process by utilizing algorithmic techniques such as sparsity and network pruning. These innovations allow users to effectively and securely train large-scale AI models on their proprietary data, while also optimizing for speed, quality, and cost. MosaicML aims to streamline the machine learning model recomposition process, making it easier for organizations to harness the power of AI in their operations.

Kentik

Series C in 2021
Kentik Technologies, Inc., established in 2014 and headquartered in San Francisco with a presence in Frankfurt, specializes in cloud-based real-time network visibility and analytics solutions. Its flagship product, Kentik Detect, is a big data-driven SaaS platform that transforms network data into actionable intelligence. Kentik serves a diverse range of industries, including financial services, media, and telecommunications, offering solutions tailored to web enterprises and service providers. The company's portfolio includes Kentik Detect, My Kentik, and an AIOps platform, empowering network and security operators to enhance operations, optimize capacity, detect anomalies, and protect applications and services. Kentik's platform is renowned for its infinite granularity, AI-driven insights, and rapid search capabilities, making it an essential tool for network professionals across various sectors.

CH4 Global

Series A in 2021
CH4 Global Inc. is a holding company focused on producing seaweed bio-products aimed at reducing methane emissions from livestock, particularly ruminants such as cows, goats, sheep, and deer. Founded in 2019 and based in San Francisco, California, the company specializes in Asparagopsis armata, a seaweed supplement proven to decrease enteric methane emissions by up to 90%. CH4 Global operates through subsidiaries in the United States, Australia, New Zealand, and the Pacific, leveraging established scientific and technological methods to develop innovative livestock feed additives. The company aims to mitigate greenhouse gas emissions on a large scale, supporting both environmental sustainability and economic benefits for farmers and food producers through potential carbon credits and premium pricing for their products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.